Stock ADVENZYMES ADVANCED ENZYME TECHNOLOGIES LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Financials Advanced Enzyme Technologies Limited

Equities

ADVENZYMES

INE837H01020

Specialty Chemicals

Market Closed - NSE India S.E.
Other stock markets
 07:43:46 2024-04-26 am EDT 		5-day change 1st Jan Change
391.8 INR +1.41% Intraday chart for Advanced Enzyme Technologies Limited +6.96% +4.37%
Mar. 30 Advanced Enzyme Technologies Limited Announces Cessation of Kedar J. Desai as Independent Director CI
Mar. 06 Advanced Enzyme Completes Acquisition of Additional 5.9% Stake in Subsidiary JC Biotech MT

Valuation

Fiscal Period: March 2018 2019 2020 2021 2022 2023
Capitalization 1 23,800 20,387 15,914 38,541 31,539 25,943
Enterprise Value (EV) 1 23,843 19,385 14,186 35,630 28,177 21,602
P/E ratio 26.5 x 18.4 x 12.3 x 26.4 x 26.4 x 24.6 x
Yield 0.23% 0.33% 0.42% 0.26% 0.35% 0.43%
Capitalization / Revenue 6.09 x 4.83 x 3.55 x 7.68 x 5.96 x 4.8 x
EV / Revenue 6.1 x 4.59 x 3.17 x 7.1 x 5.32 x 4 x
EV / EBITDA 13 x 10.5 x 7.07 x 16 x 14.7 x 14.3 x
EV / FCF 19 x 19.8 x 21.1 x 29.1 x 38.9 x 32.1 x
FCF Yield 5.27% 5.05% 4.74% 3.43% 2.57% 3.11%
Price to Book 4.26 x 3 x 1.9 x 3.97 x 2.87 x 2.1 x
Nbr of stocks (in thousands) 111,630 111,649 111,678 111,728 111,801 111,824
Reference price 2 213.2 182.6 142.5 345.0 282.1 232.0
Announcement Date 8/20/18 7/12/19 6/22/20 8/16/21 7/27/22 7/13/23
1INR in Million2INR
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: March 2018 2019 2020 2021 2022 2023
Net sales 1 3,910 4,220 4,478 5,018 5,294 5,406
EBITDA 1 1,840 1,838 2,006 2,228 1,918 1,507
EBIT 1 1,458 1,636 1,808 2,039 1,665 1,257
Operating Margin 37.3% 38.77% 40.37% 40.62% 31.45% 23.25%
Earnings before Tax (EBT) 1 1,390 1,620 1,792 2,104 1,711 1,404
Net income 1 900.6 1,111 1,293 1,462 1,196 1,056
Net margin 23.03% 26.32% 28.87% 29.13% 22.59% 19.54%
EPS 2 8.060 9.940 11.56 13.07 10.68 9.448
Free Cash Flow 1 1,258 979.8 673.1 1,222 723.8 671.9
FCF margin 32.16% 23.22% 15.03% 24.36% 13.67% 12.43%
FCF Conversion (EBITDA) 68.35% 53.3% 33.56% 54.86% 37.74% 44.59%
FCF Conversion (Net income) 139.65% 88.22% 52.06% 83.62% 60.53% 63.6%
Dividend per Share 2 0.5000 0.6000 0.6000 0.9000 1.000 1.000
Announcement Date 8/20/18 7/12/19 6/22/20 8/16/21 7/27/22 7/13/23
1INR in Million2INR
Estimates

Balance Sheet Analysis

Fiscal Period: March 2018 2019 2020 2021 2022 2023
Net Debt 1 43 - - - - -
Net Cash position 1 - 1,002 1,728 2,911 3,362 4,341
Leverage (Debt/EBITDA) 0.0234 x - - - - -
Free Cash Flow 1 1,258 980 673 1,222 724 672
ROE (net income / shareholders' equity) 17.5% 18% 16.9% 16% 11.4% 8.57%
ROA (Net income/ Total Assets) 13.8% 13.3% 12.6% 12% 8.59% 5.84%
Assets 1 6,524 8,378 10,240 12,228 13,928 18,085
Book Value Per Share 2 50.10 60.80 75.20 86.90 98.20 110.0
Cash Flow per Share 2 5.480 2.070 7.400 17.20 23.90 8.620
Capex 1 93.9 118 507 194 281 381
Capex / Sales 2.4% 2.79% 11.31% 3.88% 5.31% 7.05%
Announcement Date 8/20/18 7/12/19 6/22/20 8/16/21 7/27/22 7/13/23
1INR in Million2INR
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Annual profits - Rate of surprise

Company calendar

Sector Other Specialty Chemicals

1st Jan change Capi.
ADVANCED ENZYME TECHNOLOGIES LIMITED Stock Advanced Enzyme Technologies Limited
+4.37% 525M
ECOLAB INC. Stock Ecolab Inc.
+11.47% 63.22B
SIKA AG Stock Sika AG
-3.47% 46.34B
GIVAUDAN SA Stock Givaudan SA
+13.72% 39.97B
FUJIFILM HOLDINGS CORPORATION Stock Fujifilm Holdings Corporation
+17.83% 25.46B
EMS-CHEMIE HOLDING AG Stock EMS-CHEMIE HOLDING AG
+7.27% 18.68B
CELANESE CORPORATION Stock Celanese Corporation
-0.57% 17.24B
POSCO FUTURE M CO., LTD. Stock Posco Future M Co., Ltd.
-21.73% 15.81B
SYMRISE AG Stock Symrise AG
+0.22% 14.9B
ALBEMARLE CORPORATION Stock Albemarle Corporation
-19.10% 13.74B
Other Specialty Chemicals
  1. Stock Market
  2. Equities
  3. ADVENZYMES Stock
  4. Financials Advanced Enzyme Technologies Limited